Potentiation of acaricidal drugs with the help of a phytocomplex that undergoes cryodestruction

The objective of this study was to develop a novel natural veterinary pharmaceutical agent for the treatment of tick and mite infections, with the aim of experimentally confirming its efficacy in vivo. The dogs selected for the experiment were divided into three groups (n = 27) according to the type of tick infection, with each group divided into three subgroups (n = 9). The first experimental group of dogs was affected by ixodid ticks, the second by sarcoptic mites, and the third by thrombidiform mites. The groups were then subdivided into three smaller groups. Group I received treatment with ‘AnimAll VetLine’ antiparasitic tablets for dogs and cats, Group II received treatment with ‘Acaro Spectra’ antiparasitic tablets for dogs, and Group III served as the control group, whose condition was monitored without treatment. The antiparasitic tablets, designated ‘Acaro Spectra’, demonstrated efficacy within 24 hours. The test results indicated that the ticks were removed within the same timeframe, and no new ticks attached. Additionally, the administration of ‘Acaro Spectra’ did not elicit any allergic reactions or signs of distress in the animals. In the treatment of dogs affected by ixodid ticks, sarcoptic, and thrombidiform mites, the drug ‘Acaro Spectra’ antiparasitic tablets for dogs showed 100% effectiveness. The results obtained allow us to recommend the drug ‘Acaro Spectra’ antiparasitic tablets for dogs for the treatment and prevention of ixodid ticks (Ixodes ricinus, Rhipicephalus sanguineus, Dermacentor reticulatus), sarcoptic mites (Otodectes cynotis, Notoedres cati, Sarcoptes canis), thrombidiform mites (Demodex spp., Cheyletiella spp.)